NIH Registers NCT07550049 Genomic Cancer Mapping Study
Summary
NIH has registered NCT07550049, an observational ancillary laboratory study titled 'Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology.' The study will collect and bank blood and tissue biospecimens for future research into predictive biomarkers and genomic alterations and their correlation with clinical outcomes. Conditions include Small Cell Lung Cancer, Head and Neck Cancer, and Malignant Pleural Mesothelioma.
“This is an ancillary laboratory study to collect and bank blood and tissue samples.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
NCT07550049 is a newly registered observational study by NIH under ClinicalTrials.gov. The study will collect and bank blood and tissue biospecimens from patients diagnosed with Small Cell Lung Cancer, Head and Neck Cancer, or Malignant Pleural Mesothelioma for future genomic and biomarker research. Participants will undergo blood and tissue collection procedures as the sole intervention.
Institutions conducting thoracic or head and neck oncology research should be aware of this ancillary study as it may complement or relate to ongoing clinical programs. The biospecimens collected may support future predictive biomarker discovery and clinical outcome correlation studies. Researchers seeking to collaborate or reference this registry should note the NCT identifier for any future protocol development.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology
Observational NCT07550049 Kind: OBSERVATIONAL Apr 24, 2026
Abstract
This is an ancillary laboratory study to collect and bank blood and tissue samples. The biospecimens collected for this study will be invaluable for future research into predictive biomarkers and genomic alterations and their correlation with clinical outcomes.
Conditions: Small Cell Lung Cancer, Head and Neck Cancer, Malignant Pleural Mesothelioma
Interventions: Blood and Tissue Collection
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.